Related Experiment Videos
[Methods for systematic listing of medication in the elderly]
Christian Chinyama Broge Richelsen1, Tore Sloth Andersen, Birgitte Klindt Poulsen
1FAM – Fælles Akut Modtagelse, Odense Universitetshospital, Svendborg Sygehus. chinyamacbr@hotmail.com
Ugeskrift for Laeger
|August 20, 2013
Summary
The Beers 2003 criteria and newer STOPP/START criteria are screening tools for elderly medication. STOPP/START criteria are more effective and user-friendly for optimizing geriatric pharmacotherapy.
Area of Science:
- Geriatric pharmacotherapy
- Medication safety in the elderly
Background:
- Several screening tools exist to optimize medication regimens in older adults.
- The Beers 2003 criteria are widely utilized, but newer tools offer potential advantages.
Purpose of the Study:
- To compare the Beers 2003 criteria and the STOPP/START criteria based on desired properties.
- To propose an optimal template for a Danish medication screening tool for the elderly.
Main Methods:
- Literature review and comparative analysis of existing medication screening tools.
- Evaluation based on predefined desirable characteristics for clinical applicability.
Main Results:
- The STOPP/START criteria demonstrate greater effectiveness and ease of use compared to the Beers 2003 criteria.
- Identification of key features for a tailored Danish screening tool.
Conclusions:
- The STOPP/START criteria represent a more advantageous approach for medication review in the elderly.
- Further research is needed to confirm the clinical outcomes and health economic impact of implementing such tools.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...